Generation Bio Co. (GBIO) Stock Analysis
DELISTED 2026
What happened to Generation Bio Co. (GBIO) stock?
Generation Bio Co. (GBIO) no longer trades on public markets. It was delisted in February 2026. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- February 2026
- Last recorded price (historical):
- $5.34 (last quote on record before the February 2026 delisting; historical, not a current quote)
Market cap $36.0M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Generation Bio Co. (GBIO). Generation Bio Co. is a genetic medicines company focused on developing therapies for rare and prevalent diseases affecting the liver, retina, skeletal muscle, central nervous system, and oncology.
Last analyzed: Jun 14, 2026These figures come from statements filed 13 months ago — the most recent this company has published.
Generation Bio Co. (GBIO) Healthcare & Pipeline Overview
More about this archive record
Can I still buy GBIO shares?
No. GBIO stopped trading on public markets in February 2026, so the shares are not available through a broker. Anything you see quoted for GBIO elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before GBIO stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Generation Bio Co.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.